paclitaxel,sotigalimab,nivolumab
bms
['prince', 'pancreatic']
today at asco: we've begun to identify who might respond to immunotherapy in pancreatic cancer. i'm presenting results of the collaborative prince trial. talk is 4:30 cdt in d1 and the paper will be out in nature medicine. see you there! #asco22 #pancreaticcancer #immunotherapy
Data scientist, cancer immunotherapy researcher | VP of Informatics @parkerici | Tweets are my own